Andrew Guggenhime Insider Trades & Stock Holdings

PRESIDENT AND CFO · Vaxcyte, Inc. · Latest filing Jun 18, 2026

Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc. has 2 Form 4 trades on file since Jun 18, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($530K), net -$530K. Latest filing: disposed of 10K shares of $PCVX on Jun 18, 2026 at $53.

Trades on file

2

Open-market bought

$0

Open-market sold

$530K

Net open-market

-$530K

Latest filing

Jun 18, 2026

All insider trades by Andrew Guggenhime

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 18, 2026	$PCVX	Sell (Open-market sale) 10b5-1	10K	$53	$530K			+4.4%	+7.9%		PRESIDENT AND CFO		Read
Jun 18, 2026	$PCVX	Buy (Option exercise)	10K	$5.35	$53.50K			+4.4%	+7.9%		PRESIDENT AND CFO		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Andrew Guggenhime traded

• $PCVX

Frequently asked questions

Has Andrew Guggenhime been buying or selling stock?

Andrew Guggenhime has 0 open-market purchases and 1 open-market sale on file, net -$530K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Andrew Guggenhime's latest insider trade?

disposed of 10K shares of $PCVX on Jun 18, 2026 at $53.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.